ArticleCancers2023

Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study.

Teresa Caballero-Velázquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.